https://www.contagionlive.com/view/f2g-announces-fda-filing-acceptance-of-nda-for-the-treatment-of-invasive-fungal-infections
0
0
12/19/22 at 1:18pm
Organization
Contagionlive.com
Author
John Parkinson
The New Drug Application (NDA) for the company’s investigational therapy, Olorofim, looks to serve an unmet medical need in this treatment space.
Create an account
or login to join the discussion